<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>the Pharmaceutical companies community of South Africa</title><link>http://medical.bizcommunity.com//196/326.html</link><description>South Africa pharmaceutical companies news</description><ttl>15</ttl><category>Pharmaceutical companies news - South Africa</category><image><url>http://www.bizcommunity.com/res/img/11/logo5.gif</url><title>Bizcommunity.com</title><link>http://www.bizcommunity.com/</link></image><language>en-us</language><pubDate>Sat, 04 Jul 2009 12:09:42 +0200</pubDate><item><title>ATKA Pharma renews contract with X/procure</title><link>http://www.bizcommunity.com/Article/196/326/36027.html</link><description>&lt;p&gt;&lt;img src="http://mars.bizcommunity.com/c/0905/30543.jpg?r=0" width="65" height="69" align="left"  /&gt;ATKA Pharma has confirmed a one-year deal with the electronic procurement specialist, X/procure. The partnership started with an &amp;quot;Intervention&amp;quot; advertising campaign for its liquid Immunodulator called Biobalance Immunova.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/36027.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=36027"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/36027.html</guid><pubDate>Mon, 18 May 2009 11:42:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>bioMerieux forges unique BEE partnership</title><link>http://www.bizcommunity.com/Article/196/326/34390.html</link><description>&lt;p&gt;The partnership is between bioMérieux and Litha Healthcare Holdings&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/34390.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=34390"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/34390.html</guid><pubDate>Mon, 30 Mar 2009 10:35:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Austell Laboratories turns four</title><link>http://www.bizcommunity.com/Article/196/326/34078.html</link><description>&lt;p&gt;&lt;img src="http://mars.bizcommunity.com/c/0903/27931.jpg?r=0" width="65" height="43" align="left"  /&gt;Independent, Johannesburg-based pharmaceutical company Austell Laboratories will celebrate its fourth birthday in April 2009. Initially the company was established as Camox Pharmaceuticals in 2000 with an initial focus on tender-based products. In 2005 the company entered the private market and Austell Laboratories (Pty) Ltd was established.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/34078.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=34078"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/34078.html</guid><pubDate>Fri, 20 Mar 2009 11:39:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Fine Healthcare in partnership with Smith and Nephew</title><link>http://www.bizcommunity.com/Article/196/326/33609.html</link><description>&lt;p&gt;Johannesburg, South Africa - 6 March, 2009 - For over 150 years, Smith &amp; Nephew has developed advanced medical devices for healthcare professionals around the world.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/33609.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=33609"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/33609.html</guid><pubDate>Tue, 10 Mar 2009 09:36:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Aspen's interim results</title><link>http://www.bizcommunity.com/Article/196/326/33498.html</link><description>&lt;p&gt;Aspen's offshore operations drive an impressive 91% revenue increase.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/33498.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=33498"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/33498.html</guid><pubDate>Thu, 05 Mar 2009 14:32:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>TLC and Cipla tell men The Bald Truth</title><link>http://www.bizcommunity.com/Article/196/326/33485.html</link><description>&lt;p&gt;Supplementing the launch of its anti-balding solution for men, the pharmaceutical giant, Cipla, has commissioned Primedia Unlimited subsidiary, The Letter Corporation, to run a month's advertising campaign in men's washrooms at Virgin Active and Planet Fitness gyms countrywide.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/33485.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=33485"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/33485.html</guid><pubDate>Thu, 05 Mar 2009 13:56:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>iNova pharmaceuticals launch new South African head office</title><link>http://www.bizcommunity.com/Article/196/326/33297.html</link><description>&lt;p&gt;&lt;img src="http://mars.bizcommunity.com/c/0903/26818.jpg?r=0" width="65" height="55" align="left"  /&gt;JOHANNESBURG: iNova Pharmaceuticals last week launched their new South African head office situated in Bedfordview, Johannesburg. iNova Pharmaceuticals country manager, Dr Irwin Juckes officially opened the offices at a red ribbon cutting ceremony  attended by iNova Pharmaceuticals directors based in Sydney,  Australia, local partners, stakeholders and the media.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/33297.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=33297"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/33297.html</guid><pubDate>Mon, 02 Mar 2009 09:40:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Pfizer discontinues development of two phase two compounds</title><link>http://www.bizcommunity.com/Article/196/326/33168.html</link><description>&lt;p&gt;Pfizer Inc announced recently that, following a review of the development and commercial portfolios in the Primary Care Business Unit, it is terminating Phase 3 development programs for the investigational compounds esreboxetine for fibromyalgia and PD 332,334 for generalized anxiety disorder (GAD).&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/33168.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=33168"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/33168.html</guid><pubDate>Wed, 25 Feb 2009 11:40:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Pfizer announces results of aromasin in post-menopausal women with hormone sensitive breast cancer</title><link>http://www.bizcommunity.com/Article/196/326/31852.html</link><description>&lt;p&gt;Results Presented During the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/31852.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=31852"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/31852.html</guid><pubDate>Wed, 21 Jan 2009 11:02:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item><item><title>Cipla Renews with X/procure® for 4th Consecutive Year</title><link>http://www.bizcommunity.com/Article/196/326/31747.html</link><description>&lt;p&gt;Cipla Medpro continues to entrust the promotion of its brands through procurement specialists X/Procure®, ensuring over 1500 pharmacists are acutely aware of Cipla's offerings with communication delivered straight to the pharmacists' PC or laptop.&lt;br /&gt; &lt;a href="http://www.bizcommunity.com/Article/196/326/31747.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=326&amp;ct=1&amp;ci=31747"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/326/31747.html</guid><pubDate>Mon, 19 Jan 2009 07:54:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/326.html</source></item></channel></rss>